Renishaw plc — Cyborg Score 7/10

Strategic Profile

Renishaw is one of the world's leading engineering and scientific technology companies with expertise in precision measurement and healthcare, supplying products used in applications ranging from jet engine and wind turbine manufacturing to dentistry and brain surgery. With over 5,000 employees across 36 countries and 95% export-derived revenue of £691.3 million (FY2024), the company maintains a strong global market position.

Cyborg Score Rationale

With a market cap of £2.57B and strong fundamentals in precision measurement and healthcare sectors, Renishaw demonstrates solid market positioning. However, mixed regional performance and near-term growth headwinds temper the outlook.

Top Insights

• Dual-segment model balances mature metrology business with growth-oriented healthcare and additive manufacturing divisions
• Exceptional export orientation (95% of revenue) provides global revenue diversification but exposes to currency and geopolitical risks
• Strategic product portfolio spans industrial metrology, additive manufacturing, spectroscopy, and neurosurgical innovations
• Over 50 years of engineering heritage (founded 1973) provides brand strength and customer lock-in in precision applications

Named Competitors

• Dassault Systemes — CAD/PLM and 3D design software solutions
• Coordinate Measuring Machines & Measurement Systems — Precision measurement and positioning technologies
• Spectroscopy & Analysis Equipment — Environmental and analytical measurement instruments

Recent Developments

• (March 2026) Q1 FY2026 trading update showing OCC revenue growth of +2.8%, below consensus expectations
• (Feb 2026) Deutsche Bank raised price target to 3,940 GBp from 3,340 GBp
• (Jan 2026) Jefferies raised price target to 3,530 GBp from 2,450 GBp, maintaining Hold rating

Open the full interactive Renishaw plc report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.